BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 31, 2011
View Archived Issues
First-in-class agent lowers blood pressure in patients with heart failure
Read More
Final phase I data presented on Transgene hepatitis C vaccine
Read More
Helicon Therapeutics begins phase I/II trial of galanin GAL3 receptor antagonist for depression
Read More
Novel inhibitors of chemokine CCR2/CCR5 receptors described
Read More
Gilead discloses data on HCV NS3 inhibitor
Read More
Clinical data presented on doxazosin/dutasteride in men with benign prostatic hyperplasia
Read More
New anti-HIV agents prepared by GlaxoSmithKline
Read More
New inhibitors of mitogen-activated protein kinase kinase 7 claimed
Read More
Novel metabotropic glutamate mGlu4 receptor positive allosteric modulators patented
Read More
Chinese institute presents novel sodium/glucose cotransporter 2 inhibitors
Read More
Novacta Biosystems prepares novel antibacterial agents
Read More
Promising results emerge from phase IIb trial of PT-005
Read More
Preclinical program of afamelanotide for erythropoietic protoporphyria completed
Read More
Aeterna Zentaris reports encouraging phase III data on AEZS-130
Read More
Sunshine Biopharma reports on study of Adva-27a in human liver microsomes
Read More
Adamis Pharmaceuticals enrolls first patient into phase I/IIa study of APC-100
Read More
Eisai and Toyama Chemical submit MAA in Japan for iguratimod
Read More
Bionovo reports data from Menerba trial in postmenopausal women
Read More
Zymeworks and Merck & Co. to collaborate
Read More
GE Healthcare relaunches ready-to-use diagnostic ultrasound contrast agent in Europe
Read More
First patient dosed in phase I study of ZIN ATI-001
Read More
New Curemark product shows promise to treat hyperactivity
Read More
AdventRx to discuss key programs with FDA
Read More
BiondVax receives clearance for phase II Multimeric-001 study
Read More
Valeant Pharmaceuticals outlines offer to acquire Afexa Life Sciences
Read More
Pharming and Swedish Orphan Biovirum announce new Ruconest launch
Read More